Vaxin
Gaithersburg, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
SR
Scot RobertsExecutive Officer
FG
Florent GrosDirector
PH
Philip HodgesDirector
KS
Klaus SchaferDirector
WE
William EnrightExecutive Officer, Director
MS
Marten SteenDirector
DD
David DrutzDirector
PP
Philippe PoulettyDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$8MraisedMar 2015 · 7 investors · BiotechnologyRule 506(b)
▶$8MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David DrutzDirector
- Klaus SchaferDirector
- Philip HodgesDirector
- Scot RobertsExecutive Officer
- Florent GrosDirector
- Philippe PoulettyDirector
- Marten SteenDirector
- William EnrightExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $8M
- Minimum investment
- $10
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$42MraisedMar 2015 · 60 investors · BiotechnologyRule 506(b)
▶$42MraisedMar 2015 · 60 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe PoulettyDirector
- Scot RobertsExecutive Officer
- Florent GrosDirector
- Philip HodgesDirector
- Klaus SchaferDirector
- William EnrightExecutive Officer, Director
- Marten SteenDirector
- David DrutzDirector
- Offering amount
- $42M
- Amount sold
- $42M
- Sales commissions
- $520K
- Placement agents
- Gordian Investment, LLC
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.